smoking cessation

Read more about the article CoEHAR exposes for the first time that most e-cigarette research is flawed and in need of urgent critical reform 

CoEHAR exposes for the first time that most e-cigarette research is flawed and in need of urgent critical reform 

Under the leadership of CoEHAR, a team of international researchers, examined the 24 most frequently cited vaping studies published in medical journals. The findings are shocking: almost all of these studies were found to be methodologically flawed; they lacked a clear hypothesis, used inadequate methodology, failed to collect data relevant to the study objectives, and did not correct for obvious confounding factors. 

Continue ReadingCoEHAR exposes for the first time that most e-cigarette research is flawed and in need of urgent critical reform 
Read more about the article Smokers and Covid-19 risk: a new CoEHAR study confirms that vaccines are less effective on smokers

Smokers and Covid-19 risk: a new CoEHAR study confirms that vaccines are less effective on smokers

According to the researchers from CoEHAR, the Center of Excellence for the acceleration of Harm Reduction of the University of Catania, in partnership with the University of Pavia and the University of Milan “Statale”, the analysis of the international studies conducted on the humoral response to Covid-19 vaccines confirmed the negative impact of smoking on antibodies levels induced by vaccine and the rapid lowering of the vaccine-elicited IgG titres over six months

Continue ReadingSmokers and Covid-19 risk: a new CoEHAR study confirms that vaccines are less effective on smokers
Read more about the article The geography of Harm Reduction: while snus and chewing tobacco are distributed worldwide, the literature is incomplete and deceiving

The geography of Harm Reduction: while snus and chewing tobacco are distributed worldwide, the literature is incomplete and deceiving

The widespread availability of safer nicotine delivery systems without the harms from tobacco, as has been demonstrated for Swedish snus and some other forms of smokeless tobacco products, is a route to ending smoking in the not too distant future as we are already witnessing in Sweden and Norway. A clear distinction needs to be made between the safer snus and refined smokeless tobacco products used in Sweden, Norway and increasingly in the US, and the far riskier unrefined SLT products used in Asia, Middle East and Africa

Continue ReadingThe geography of Harm Reduction: while snus and chewing tobacco are distributed worldwide, the literature is incomplete and deceiving
Read more about the article Prof. Caruso, from CoEHAR, joined CORESTA SSPT2021 Conference

Prof. Caruso, from CoEHAR, joined CORESTA SSPT2021 Conference

The main goal of the Conference is to introduce the current status of New Alternative Methods and their potential to support Tobacco Harm Reduction worldwide. The aim of the CORESTA conference is also to foster scientific engagement between CORESTA members and THR international community to facilitate the discussion around reduced risk devices and support evidence-based tobacco regulatory policies.

Continue ReadingProf. Caruso, from CoEHAR, joined CORESTA SSPT2021 Conference
Read more about the article Harm Reduction and bias: a review confirms that ecigs are less harmful, but high-quality studies are much needed

Harm Reduction and bias: a review confirms that ecigs are less harmful, but high-quality studies are much needed

"It is surprising to note that there are very few studies that can be considered truly informative of the risk-benefit ratio of new technologies with reduced risk in terms of their impact on health. We are proud to say that CoEHAR research ranks among the best in the current scientific landscape"

Continue ReadingHarm Reduction and bias: a review confirms that ecigs are less harmful, but high-quality studies are much needed
Read more about the article The CoEHAR smile operation has started: enrolled the first patient of Smile Study

The CoEHAR smile operation has started: enrolled the first patient of Smile Study

With the enrollment of the first patient, the project has officially started, thanks to the collaboration of international renew partners: the Addendo Clinic (Catania), the University of Modena and Reggio Emilia, the University of Bologna, and research centres in Warsaw (Poland), Chisinau (Moldova) and Bandung (Indonesia).

Continue ReadingThe CoEHAR smile operation has started: enrolled the first patient of Smile Study
Read more about the article DIASMOKE: the patient recruitment phase has officially started

DIASMOKE: the patient recruitment phase has officially started

CoEHAR, the Center of Excellence for the acceleration of Harm Reduction of the University of Catania, has launched a two-year study, the Diasmoke project, to investigate whether vaping or using E-cigarettes reduces the risk of cardiovascular (heart and circulation) disease as compared to normal smoking.

Continue ReadingDIASMOKE: the patient recruitment phase has officially started